Tempus AI Stock
StockStockPrice
Frequently asked questions
What is Tempus AI's market capitalization?
What is the Earnings Per Share (EPS) for Tempus AI?
What is Tempus AI's revenue over the trailing twelve months?
What is the EBITDA for Tempus AI?
How many employees does Tempus AI have, and what sector and industry does it belong to?
What is the free float of Tempus AI's shares?
Financials
Market Cap
$12.22BEPS (TTM)
-$8.287Free Float
57.12MRevenue (TTM)
$640.44MEBITDA (TTM)
-$656.16MPricing
Information
Tempus AI, Inc. is a technology company. The Company provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Company’s product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The Company's AI applications are focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.
2,300
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker